Literature DB >> 21642052

[Epidemiology of malignant melanoma (Clinical experience at the National Institute of Oncology in Hungary)].

Tímea Balatoni1, Gabriella Liszkay, Zoltánné Miklós, Miklós Kásler.   

Abstract

UNLABELLED: The National Cancer Registry, which has been running since 1999 in Hungary, supplies more and more precise data about the growing incidence of malignant melanoma although nationwide melanoma database currently does not exist. As in the National Institute of Oncology a notable percentage of patients (20-25%) were treated with newly diagnosed melanoma, conclusions may be drawn for the efficacy of primary prevention for the whole country.
METHODS: The recent study compares the data of patients presented in the Institute with cutaneous malignant melanoma in 1998 and ten years later, in 2008. The histology parameters of tumors were also analyzed. The two groups were compared according to age, gender, localization and histology parameters (histological types Breslow and Clark numbers). In case of continuous variables the Mann-Whitney test were used to determine significant differences. Categorical variables were checked by χ2 test.
RESULTS: 149 and 377 cutaneous melanomas were diagnosed in 1998 and in 2008, respectively, which accounts for 153% increase in ten years. The mean age of patients was 56.3 and 57.2 years in 1998 and in 2008, respectively. The per cent of males was 43% in 1998 and 49% in 2008. Trunk was the most frequent localization in both years: 39% and 46%, then lower limbs (28% and 22%), upper limbs (21% and 18%) and the head and neck region (12% and 14%). Superficial melanoma was found the most frequent histological type (52 and 54%) followed by nodular melanoma (31% and 23%). Rate of in situ melanoma changed from 10% to 15%. The mean of Breslow numbers was 2.2 mm in 1998 and 1.6 mm in 2008, the difference was highly significant (p = 0.0002). Clark numbers were also decreasing, although the difference was not significant (p = 0.08). The majority of patients were presented with Clark III depth melanoma in both years (38% and 32%).
CONCLUSIONS: It seems that forces emphasizing the importance of early recognition in medical education and in media are not futile considering that principally the early diagnosis can improve the melanoma's prognosis - which is represented mainly by Breslow tumor depth.

Entities:  

Mesh:

Year:  2011        PMID: 21642052     DOI: 10.1556/OH.2011.29148

Source DB:  PubMed          Journal:  Orv Hetil        ISSN: 0030-6002            Impact factor:   0.540


  2 in total

1.  Changing Trends in Melanoma Incidence and Decreasing Melanoma Mortality in Hungary Between 2011 and 2019: A Nationwide Epidemiological Study.

Authors:  Gabriella Liszkay; Zoltan Kiss; Roland Gyulai; Judit Oláh; Péter Holló; Gabriella Emri; András Csejtei; István Kenessey; Angela Benedek; Zoltán Polányi; Zsófia Nagy-Erdei; Andrea Daniel; Kata Knollmajer; Máté Várnai; Zoltán Vokó; Balázs Nagy; György Rokszin; Ibolya Fábián; Zsófia Barcza; Csaba Polgár
Journal:  Front Oncol       Date:  2021-02-12       Impact factor: 6.244

2.  Improving Quality Indicator of Melanoma Management - Change of Melanoma Mortality-to-Incidence Rate Ratio Based on a Hungarian Nationwide Retrospective Study.

Authors:  Máté Várnai; Zoltán Kiss; Rolland Gyulai; Judit Oláh; Péter Holló; Gabriella Emri; András Csejtei; István Kenessey; Angéla Benedek; Zoltán Polányi; Zsófia Nagy-Erdei; Andrea Dániel; Kata Knollmajer; György Rokszin; Ibolya Fábián; Zsófia Barcza; Csaba Polgár; Balázs Nagy; Gabriella Liszkay; Zoltán Vokó
Journal:  Front Oncol       Date:  2021-10-19       Impact factor: 6.244

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.